Phod\u00e9<\/a> est le premier laboratoire internationalement reconnu pour son expertise dans l\u2019impact des mol\u00e9cules olfactives sur l\u2019\u00e9cosyst\u00e8me c\u00e9r\u00e9bral. Le groupe se sp\u00e9cialise dans la conception, la production et la commercialisation de solutions olfactives naturelles agissant en faveur du Mieux-\u00catre de l\u2019Homme, des Animaux et de l\u2019Environnement.<\/p>\nAvec plus de 20 M\u20ac de chiffre d\u2019affaires, le Groupe a connu une phase de d\u00e9veloppement rapide depuis sa cr\u00e9ation avec 10% de croissance par an au cours des dix derni\u00e8res ann\u00e9es. Son succ\u00e8s repose sur un mod\u00e8le \u00e9conomique r\u00e9silient conciliant des initiatives de recherche et d\u00e9veloppement pionni\u00e8res et une expansion commerciale continue. Pr\u00e9sent \u00e0 l\u2019international, le groupe Phod\u00e9 g\u00e9n\u00e8re 70% de ses ventes hors de France en s\u2019appuyant sur son r\u00e9seau de distributeurs et ses filiales en Chine, Afrique du Sud et Canada.<\/p>\n
Aux c\u00f4t\u00e9s du dirigeant fondateur Daniel Eclache, Turenne Sant\u00e9 fait son entr\u00e9e au capital de Phod\u00e9 dans le cadre d\u2019une op\u00e9ration permettant l\u2019entr\u00e9e de cadres-cl\u00e9s emmen\u00e9s par Damien Guillobez (nouveau Directeur G\u00e9n\u00e9ral) et la sortie d\u2019actionnaires minoritaires parmi lesquels figure Oraxys Environment I. Cette op\u00e9ration vise \u00e0 soutenir le rythme de croissance soutenu du groupe et le bon d\u00e9ploiement d\u2019un business plan ambitieux qui pr\u00e9voit un doublement du chiffre d\u2019affaires d\u2019ici 2026.<\/p>\n
Notre r\u00f4le<\/h2>\n
Investec a assist\u00e9 les actionnaires tout au long de l\u2019op\u00e9ration : d\u00e9finition de la strat\u00e9gie de l\u2019op\u00e9ration et de l\u2019equity story, pr\u00e9paration des actionnaires \u00e0 leur premier LBO avec un partenaire financier, r\u00e9daction de la documentation marketing en lien avec l\u2019equity story et le projet de croissance, approche et discussions avec les fonds d\u2019investissement les plus pertinents, s\u00e9curisation du financement bancaire pour l\u2019op\u00e9ration, mise en place du bon degr\u00e9 de tension concurrentielle afin de maximiser les termes de l\u2019op\u00e9ration (valeur, calendrier, gouvernance), pilotage du process avec les conseils et phases de n\u00e9gociation.<\/p>\n","protected":false},"excerpt":{"rendered":"
Contexte de l’op\u00e9ration Fond\u00e9 en 1996 par Daniel Eclache, Phod\u00e9 est le premier laboratoire internationalement reconnu pour son expertise dans…<\/p>\n","protected":false},"featured_media":0,"template":"","dt":[],"sector":[3732,3768],"dealtype":[3706,3718,3740],"clienttype":[3729,3720],"class_list":["post-30237","deals","type-deals","status-publish","hentry","sector-agroalimentaire-fr","sector-healthcare-fr","dealtype-cession-fr","dealtype-debt-advisory-fr","dealtype-capital-dev-fr","clienttype-entrepreneurs-fr","clienttype-pe-fr"],"acf":[],"yoast_head":"\n
LBO de Phod\u00e9 | Investec Business Advisory<\/title>\n<meta name=\"description\" content=\"Phod\u00e9 est le premier laboratoire internationalement reconnu dans l\u2019impact des mol\u00e9cules olfactives sur l\u2019\u00e9cosyst\u00e8me c\u00e9r\u00e9bral\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LBO de Phod\u00e9\" \/>\n<meta property=\"og:description\" content=\"Phod\u00e9 est le premier laboratoire internationalement reconnu dans l\u2019impact des mol\u00e9cules olfactives sur l\u2019\u00e9cosyst\u00e8me c\u00e9r\u00e9bral\" \/>\n<meta property=\"og:url\" content=\"https:\/\/working.capitalmind.com\/fr\/deals\/mbo-phode\/\" \/>\n<meta property=\"og:site_name\" content=\"Investec Business Advisory\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-05T15:00:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/deals\/mbo-phode\/\",\"url\":\"https:\/\/working.capitalmind.com\/fr\/deals\/mbo-phode\/\",\"name\":\"LBO de Phod\u00e9 | Investec Business Advisory\",\"isPartOf\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#website\"},\"datePublished\":\"2022-02-22T08:50:50+00:00\",\"dateModified\":\"2023-06-05T15:00:00+00:00\",\"description\":\"Phod\u00e9 est le premier laboratoire internationalement reconnu dans l\u2019impact des mol\u00e9cules olfactives sur l\u2019\u00e9cosyst\u00e8me c\u00e9r\u00e9bral\",\"breadcrumb\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/deals\/mbo-phode\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/working.capitalmind.com\/fr\/deals\/mbo-phode\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/deals\/mbo-phode\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/working.capitalmind.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LBO de Phod\u00e9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#website\",\"url\":\"https:\/\/working.capitalmind.com\/fr\/\",\"name\":\"Investec Business Advisory\",\"description\":\"Investec Business Advisory\",\"publisher\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/working.capitalmind.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#organization\",\"name\":\"Capitalmind Investec\",\"url\":\"https:\/\/working.capitalmind.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg\",\"contentUrl\":\"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg\",\"width\":1120,\"height\":1121,\"caption\":\"Capitalmind Investec\"},\"image\":{\"@id\":\"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory\",\"https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"LBO de Phod\u00e9 | Investec Business Advisory","description":"Phod\u00e9 est le premier laboratoire internationalement reconnu dans l\u2019impact des mol\u00e9cules olfactives sur l\u2019\u00e9cosyst\u00e8me c\u00e9r\u00e9bral","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"LBO de Phod\u00e9","og_description":"Phod\u00e9 est le premier laboratoire internationalement reconnu dans l\u2019impact des mol\u00e9cules olfactives sur l\u2019\u00e9cosyst\u00e8me c\u00e9r\u00e9bral","og_url":"https:\/\/working.capitalmind.com\/fr\/deals\/mbo-phode\/","og_site_name":"Investec Business Advisory","article_modified_time":"2023-06-05T15:00:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/working.capitalmind.com\/fr\/deals\/mbo-phode\/","url":"https:\/\/working.capitalmind.com\/fr\/deals\/mbo-phode\/","name":"LBO de Phod\u00e9 | Investec Business Advisory","isPartOf":{"@id":"https:\/\/working.capitalmind.com\/fr\/#website"},"datePublished":"2022-02-22T08:50:50+00:00","dateModified":"2023-06-05T15:00:00+00:00","description":"Phod\u00e9 est le premier laboratoire internationalement reconnu dans l\u2019impact des mol\u00e9cules olfactives sur l\u2019\u00e9cosyst\u00e8me c\u00e9r\u00e9bral","breadcrumb":{"@id":"https:\/\/working.capitalmind.com\/fr\/deals\/mbo-phode\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/working.capitalmind.com\/fr\/deals\/mbo-phode\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/working.capitalmind.com\/fr\/deals\/mbo-phode\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/working.capitalmind.com\/fr\/"},{"@type":"ListItem","position":2,"name":"LBO de Phod\u00e9"}]},{"@type":"WebSite","@id":"https:\/\/working.capitalmind.com\/fr\/#website","url":"https:\/\/working.capitalmind.com\/fr\/","name":"Investec Business Advisory","description":"Investec Business Advisory","publisher":{"@id":"https:\/\/working.capitalmind.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/working.capitalmind.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/working.capitalmind.com\/fr\/#organization","name":"Capitalmind Investec","url":"https:\/\/working.capitalmind.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","contentUrl":"https:\/\/working.capitalmind.com\/wp-content\/uploads\/2020\/01\/Logo_Investec_cmjn_6.jpg","width":1120,"height":1121,"caption":"Capitalmind Investec"},"image":{"@id":"https:\/\/working.capitalmind.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/capitalmind---corporate-finance-advisory","https:\/\/www.youtube.com\/channel\/UC4bVt7iNejh8tGT6Qfa9R4w"]}]}},"_links":{"self":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals\/30237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/types\/deals"}],"wp:attachment":[{"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/media?parent=30237"}],"wp:term":[{"taxonomy":"dt","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/dt?post=30237"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/sector?post=30237"},{"taxonomy":"dealtype","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/dealtype?post=30237"},{"taxonomy":"clienttype","embeddable":true,"href":"https:\/\/working.capitalmind.com\/fr\/wp-json\/wp\/v2\/clienttype?post=30237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}